Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey
- 23 May 2022
- journal article
- research article
- Published by Elsevier in Archives de Pédiatrie
- Vol. 29 (6) , 415-423
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Autophagy in lysosomal storage disordersAutophagy, 2012
- Common and Uncommon Pathogenic Cascades in Lysosomal Storage DiseasesJournal of Biological Chemistry, 2010
- Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1Neurobiology of Disease, 2009
- NSAIDs increase survival in the Sandhoff disease mouse: Synergy with N‐butyldeoxynojirimycinAnnals of Neurology, 2004
- Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral NucleocapsidThe Journal of Infectious Diseases, 2004
- Possible role of autoantibodies in the pathophysiology of GM2 gangliosidosesJournal of Clinical Investigation, 2004
- Natural autoantibodies in sera of patients with Gaucher's diseaseJournal of Clinical Immunology, 1995
- Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotypeThe Lancet, 1995
- Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.Proceedings of the National Academy of Sciences, 1993
- Polyclonal B‐cell lymphocytosis and hypergammaglobulinemia in patients with gaucher diseaseAmerican Journal of Hematology, 1988